UNSPSC 51111743: Medorubicin
Commodity
Code facts
- Part of
-
-
51000000
-
51110000
- 51111700
-
51110000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51111743
| NIGP code |
|---|
| 26908 Anti-Infective Agents |
Definition
This classification denotes an anthracycline antibiotic with the molecular formula C26H27NO10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NU158DGH9E, chemically known as 5,12-naphthacenedione, 7,8,9,10-tetrahydro-7-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-9-(hydroxyacetyl)-6,9,11-trihydroxy-, (7s-cis)- but generally known as medorubicin, which bears US NIH Compound Identifier 68837.
Read the full definition
European Medicines Agency schedules Medorubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08695MIG. The term MEDORUBICIN is an International Non-Proprietary Name. MEDORUBICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule medorubicin under HS 29419000 and SITC 54139. As of Q4 2014, MEDORUBICIN remains the US FDA Preferred Term for this commodity. Medorubicin bears US NLM identifiers UMLS ID C0048224 and NCI Concept Code C87599.
SMILES: O(C1CC(O)(CC2C1C(O)C1C(C2O)C(=O)C2C(C1=O)CCCC2)C(=O)CO)C1OC(C(O)C(N)C1)C.
About UNSPSC 51111743
UNSPSC 51111743 Medorubicin (Commodity) represents pharmaceutical procurement activity under state and local health agencies, though recent opportunities show little direct solicitation for this specific oncology agent. The code encompasses chemotherapy and antineoplastic drugs acquired through state health department purchasing, often via cooperative pharmaceutical consortia and piggyback arrangements that allow jurisdictions to leverage existing master agreements. State and local governments use this code when procuring specialty pharmaceuticals for public health stockpiles, emergency preparedness, and direct distribution through county health departments and public clinics. Issuing bodies include state health departments, county health systems, and special-purpose districts with pharmaceutical inventory responsibilities.
The recent opportunities in the source do not reflect procurement specifically for medorubicin. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 covering antibiotic agents (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) rather than oncology drugs, and Seminole County, Florida released an IFB in June 2026 for naloxone and drug deactivation systems—both acquisitions misaligned with the code's stated scope. Neither recent opportunity demonstrates active demand for medorubicin under UNSPSC 51111743. The code shows little relevant recent activity in state and local procurement channels, suggesting either minimal current demand for this specific antineoplastic agent or alternative coding practices within health department purchasing systems.
Quick answers
What is UNSPSC 51111743?
UNSPSC 51111743 is Medorubicin, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51111743?
UNSPSC 51111743 maps to 1 NIGP code, 26908 Anti-Infective Agents.
On GovTribe
See everything under UNSPSC 51111743
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code